CITRONOWICZ MOSHE 4

What Happened Moshe Citronowicz, Senior Vice President of Apyx Medical Corp (APYX), exercised stock options on March 15, 2026. He purchased 37,000 shares at an exercise price of $1.80 per share, paying $66,600 in total. The filing shows the related derivative was converted into common stock (exercise transaction code M).

Key Details

• Transaction date: March 15, 2026. Form filed March 17, 2026 (timely; within the Form 4 two-business-day window).
• Exercise: 37,000 options exercised at $1.80/share = $66,600 cash paid.
• Filing shows a companion line disposing of the derivative instrument at $0.00, indicating conversion of the option into shares (not a sale of the underlying shares).
• Footnote: Options exercised were awarded March 16, 2016 under the Issuer’s 2015 Share Incentive Plan.
• Shares owned after the transaction: not specified in this Form 4.

Context This is an option exercise (code M). Because there is no sale reported, this transaction reflects acquisition of shares (not proceeds from a sale). The filing does not indicate a cashless exercise, tax-withholding sale, or a 10b5-1 plan. Exercises are common for employees managing option schedules and do not by themselves indicate a change in insider sentiment.